Stock RIGL RIGEL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Rigel Pharmaceuticals, Inc.

Equities

RIGL

US7665596034

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.1 USD 0.00% Intraday chart for Rigel Pharmaceuticals, Inc. +1.85% -24.14%
Apr. 12 Rigel Pharmaceuticals, Inc. Enters into Amendment No. 4 to that Certain Credit and Security Agreement CI
Mar. 12 Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rigel Pharmaceuticals : March 2024
PU
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel Announces Publication of Data on REZLIDHIA in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia and Lymphoma
AQ
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
PR
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
AQ
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
PR
Rigel Pharmaceuticals Provides Business Update
AQ
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
PR
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA in AML and Other Cancers
AQ
Rigel: Q3 Earnings Snapshot
AQ
Rigel to Present at the Jefferies London Healthcare Conference
PR
Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition
AQ
Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business Update
PR
Rigel Announces Presentation at the Upcoming IDWeek 2023
PR
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel to Present at the 2023 Cantor Global Healthcare Conference
PR
Rigel to Participate in Upcoming September Investor Conferences
PR
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RIGL Stock
  4. News Rigel Pharmaceuticals, Inc.
  5. Press Releases